J. K. Eden

Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany

A. Hoffmann, P. Breda, B. Becker, 2022, European Archives of Oto-Rhino-Laryngology.